SavedAdd your journal

Journals / Neurological sciences and neurophysiology (Online) / 2022 / Cilt: 39 - Sayı: 2

Autologous Stem Cell Transplantation in a Patient with Refractory Anti MuSK Positive Myasthenia Gravis and Familial Mediterranean Fever

Berin İnan
Pages
115–118
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

İnan, B. (2022). Autologous Stem Cell Transplantation in a Patient with Refractory Anti MuSK Positive Myasthenia Gravis and Familial Mediterranean Fever. Neurological sciences and neurophysiology (Online), Cilt: 39 - Sayı: 2, 115–118. https://ajindex.com/articles/584283

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Silvestri NJ, Wolfe GI. Myasthenia gravis. Semin Neurol 2012;32:215 26
  2. Gilhus NE. Myasthenia gravis. N Engl J Med 2016;375:2570 81
  3. Mantegazza R, Antozzi C. From traditional to targeted immunotherapy in myasthenia gravis: Prospects for research. Front Neurol 2020;11:981
  4. Suh J, Goldstein JM, Nowak RJ. Clinical characteristics of refractory myasthenia gravis patients. Yale J Biol Med 2013;86:255 60
  5. Gilhus NE, Verschuuren JJ. Myasthenia gravis: Subgroup classification and therapeutic strategies. Lancet Neurol 2015;14:1023 36
  6. Jordan A, Freimer M. Recent advances in understanding and managing myasthenia gravis. F1000Res 2018;7:v1000 727
  7. Das J, Sharrack B, Snowden JA. Autologous hematopoietic stem cell transplantation in neurological disorders: Current approach and future directions. Expert Rev Neurother 2020;20:1299 313
  8. Burman J, Tolf A, Hägglund H, Askmark H. Autologous haematopoietic stem cell transplantation for neurological diseases. J Neurol Neurosurg Psychiatry 2018;89:147 55
  9. Burt RK, Statkute L, Gourineni R, Oyama Y, Blume GM, Verda L. Treatment of refractory myasthenia gravis with high dose chemotherapy and autologous hematopoietic stem cell transplantation. Neurology 2004;62:A497
  10. Strober J, Cowan MJ, Horn BN. Allogeneic hematopoietic cell transplantation for refractory myasthenia gravis. Arch Neurol 2009;66:659 61
  11. Bryant A, Atkins H, Pringle CE, Allan D, Anstee G, Bence Bruckler I, et al. Myasthenia gravis treated with autologous hematopoietic stem cell transplantation. JAMA Neurol 2016;73:652 8
  12. Håkansson I, Sandstedt A, Lundin F, Askmark H, Pirskanen R, Carlson K, et al. Successful autologous haematopoietic stem cell transplantation for refractory myasthenia gravis – A case report. Neuromuscul Disord 2017;27:90 3
  13. Tandan R, Hehir MK 2nd, Waheed W, Howard DB. Rituximab treatment of myasthenia gravis: A systematic review. Muscle Nerve 2017;56:185 96
  14. Hehir MK, Hobson Webb LD, Benatar M, Barnett C, Silvestri NJ, Howard JF Jr., et al. Rituximab as treatment for anti MuSK myasthenia gravis: Multicenter blinded prospective review. Neurology 2017;89:1069 77
  15. Nacu A, Andersen JB, Lisnic V, Owe JF, Gilhus NE. Complicating autoimmune diseases in myasthenia gravis: A review. Autoimmunity 2015;48:362 8
  16. Bekircan Kurt CE, Tuncer Kurne A, Erdem Ozdamar S, Kalyoncu U, Karabudak R, Tan E. The course of myasthenia gravis with systemic lupus erythematosus. Eur Neurol 2014;72:326 9
  17. Doria A, Zen M, Bet